Related references
Note: Only part of the references are listed.International Consensus Guidance for Management of Myasthenia Gravis 2020 Update
Pushpa Narayanaswami et al.
NEUROLOGY (2021)
Medication adherence in patients with myasthenia gravis in Brazil: a cross-sectional study
Bruno Kusznir Vitturi et al.
ACTA NEUROLOGICA BELGICA (2020)
Exploring outcomes and characteristics of myasthenia gravis: Rationale, aims and design of registry - The EXPLORE-MG registry
Rahul Anil et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Fatigue in patients with myasthenia gravis. A systematic review of the literature
Annabel M. Ruiter et al.
NEUROMUSCULAR DISORDERS (2020)
Quality of life in adults with multiple sclerosis: a systematic review
Irene Gil-Gonzalez et al.
BMJ OPEN (2020)
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Gil I. Wolfe et al.
LANCET NEUROLOGY (2019)
Eculizumab improves fatigue in refractory generalized myasthenia gravis
Henning Andersen et al.
QUALITY OF LIFE RESEARCH (2019)
Impact of autoimmune comorbidity on fatigue, sleepiness and mood in myasthenia gravis
T. M. Alekseeva et al.
JOURNAL OF NEUROLOGY (2019)
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
James F. Howard et al.
NEUROLOGY (2019)
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study
Hiroyuki Murai et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Clinical outcome measures following plasma exchange for MG exacerbation
Shruti M. Raja et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
EQ-5D-5L and SF-6D health utility index scores in patients with myasthenia gravis
C. Barnett et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Understanding side effects of therapy for myasthenia gravis and their impact on daily life
Elizabeth Dansie Bacci et al.
BMC NEUROLOGY (2019)
Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004-2014: A retrospective national registry study
Jussi O. T. Sipila et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Understanding the burden of refractory myasthenia gravis
Christiane Schneider-Gold et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations
Guntis Karelis et al.
EUROPEAN NEUROLOGY (2019)
Quality of life in patients with MuSK positive myasthenia gravis
Milica Stankovic et al.
ACTA NEUROLOGICA BELGICA (2018)
FATIGUE IS A RELEVANT OUTCOME IN PATIENTS WITH MYASTHENIA GRAVIS
Christopher Tran et al.
MUSCLE & NERVE (2018)
Epidemiology of Myasthenia Gravis in Slovakia in the Years 1977-2015
Ivan Martinka et al.
NEUROEPIDEMIOLOGY (2018)
Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology
Michael K. Hehir et al.
NEUROLOGIC CLINICS (2018)
Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis
Karen Hewett et al.
NEUROLOGY (2018)
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis
Elena Cortes-Vicente et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Lifestyle factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis
Elisabet Westerberg et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study
Silvia Bonanno et al.
SAGE OPEN MEDICINE (2018)
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
James F. Howard et al.
LANCET NEUROLOGY (2017)
COGNITIVE FATIGUE IN PATIENTS WITH MYASTHENIA GRAVIS
Berit Jordan et al.
MUSCLE & NERVE (2017)
ASSESSMENT OF PHYSICAL FATIGABILITY AND FATIGUE PERCEPTION IN MYASTHENIA GRAVIS
Berit Jordan et al.
MUSCLE & NERVE (2017)
Prevalence of myasthenia gravis in the Catalan county of Osona
J. M. Aragones et al.
NEUROLOGIA (2017)
Subcutaneous immunoglobulin in myasthenia gravis exacerbation A prospective, open-label trial
Grayson Beecher et al.
NEUROLOGY (2017)
Resistant myasthenia gravis and rituximab: A monocentric retrospective study of 28 patients
Vadim Afanasiev et al.
NEUROMUSCULAR DISORDERS (2017)
Ephedrine treatment for autoimmune myasthenia gravis
Alexander F. Lipka et al.
NEUROMUSCULAR DISORDERS (2017)
Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries
Liis Sabre et al.
BRAIN AND BEHAVIOR (2017)
Response to treatment of myasthenia gravis according to clinical subtype
Tetsuya Akaishi et al.
BMC NEUROLOGY (2016)
EFFICACY OF PREDNISONE FOR THE TREATMENT OF OCULAR MYASTHENIA (EPITOME): A RANDOMIZED, CONTROLLED TRIAL
Michael Benatar et al.
MUSCLE & NERVE (2016)
Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases
Ernestina Santos et al.
MUSCLE & NERVE (2016)
Improvement of quality of life after therapeutic plasma exchange in patients with myasthenic crisis
Izabela Rozmilowska et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2016)
Myasthenia gravis exacerbation after discontinuing mycophenolate A single-center cohort study
Bjoern Oskarsson et al.
NEUROLOGY (2016)
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
Mamatha Pasnoor et al.
NEUROLOGY (2016)
International consensus guidance for management of myasthenia gravis: Executive summary
Donald B. Sanders et al.
NEUROLOGY (2016)
Myasthenia Gravis
Nils E. Gilhus
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Randomized Trial of Thymectomy in Myasthenia Gravis
G. I. Wolfe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Beck Depression Inventory
Gordon Jackson-Koku
OCCUPATIONAL MEDICINE-OXFORD (2016)
Fatigue in myasthenia gravis: risk factors and impact on quality of life
Sarah Hoffmann et al.
BRAIN AND BEHAVIOR (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Blepharoptosis surgery in patients with myasthenia gravis
Andre S. Litwin et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry
A. Ramos-Fransi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts
M. I. Boldingh et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2015)
Geographical Distribution of Myasthenia Gravis in Northern Europe - Results from a Population-Based Study from Two Countries
Marion I. Boldingh et al.
NEUROEPIDEMIOLOGY (2015)
A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis
Donald B. Sanders et al.
NEUROTHERAPEUTICS (2015)
Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records
Anett Foldvari et al.
WIENER KLINISCHE WOCHENSCHRIFT (2015)
Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients
Iain J. McGurgan et al.
BRAIN AND BEHAVIOR (2015)
Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study
Shingo Konno et al.
PLOS ONE (2015)
Fatigue in myasthenia gravis: is it more than muscular weakness?
Ahmed Elsais et al.
BMC NEUROLOGY (2013)
A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
James F. Howard et al.
MUSCLE & NERVE (2013)
Safety of plasma exchange therapy in patients with myasthenia gravis
Hamid Ebadi et al.
MUSCLE & NERVE (2013)
Further developments with antisense treatment for myasthenia gravis
Jon Sussman et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS II (2012)
Low-Dose Glucocorticoid Therapy Complements the Pituitary-Adrenocortical System and Reduces Anxiety and Insomnia in Myasthenia Gravis Patients
Suguru Ito et al.
CLINICAL NEUROPHARMACOLOGY (2012)
MYASTHENIA GRAVIS: SLEEP QUALITY, QUALITY OF LIFE, AND DISEASE SEVERITY
Elena Hernandez Martinez De Lapiscina et al.
MUSCLE & NERVE (2012)
Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia)
Ivana Z. Basta et al.
NEUROLOGICAL SCIENCES (2012)
A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis
Jeannine M. Heckmann et al.
BMC NEUROLOGY (2011)
Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis
C. -B. Zhao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis
Wolfgang Koehler et al.
JOURNAL OF CLINICAL APHERESIS (2011)
Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis
Hiroaki Yoshikawa et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
ANTI-MuSK ANTIBODY MYASTHENIA GRAVIS: CLINICAL FINDINGS AND RESPONSE TO TREATMENT IN TWO LARGE COHORTS
Jeffrey T. Guptill et al.
MUSCLE & NERVE (2011)
Comparison of IVIg and PLEX in patients with myasthenia gravis
D. Barth et al.
NEUROLOGY (2011)
Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: Results of a prospective multicenter open-label trial
Joern Peter Sieb et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
The relationship between health, disability and quality of life in Myasthenia Gravis: results from an Italian study
Matilde Leonardi et al.
JOURNAL OF NEUROLOGY (2010)
Unsatisfactory outcomes in myasthenia gravis: influence by care providers
Murielle Dunand et al.
JOURNAL OF NEUROLOGY (2010)
Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy
Yaroslav Winter et al.
JOURNAL OF NEUROLOGY (2010)
FACTORS ASSOCIATED WITH RESPONSE TO CALCINEURIN INHIBITORS IN MYASTHENIA GRAVIS
Yuriko Nagane et al.
MUSCLE & NERVE (2010)
Identification of international classification of functioning, disability and health relevant categories to describe functioning and disability of patients with myasthenia gravis
Matilde Leonardi et al.
DISABILITY AND REHABILITATION (2009)
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated
R. A. Marrie et al.
MULTIPLE SCLEROSIS (2009)
Neuropsychological assessment in myasthenia gravis
Emilia J. Sitek et al.
NEUROLOGICAL SCIENCES (2009)
Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement
Kai Bachmann et al.
SURGERY (2009)
MYCOPHENOLATE MOFETIL AS SECOND LINE IMMUNOSUPPRESSANT IN MYASTHENIA GRAVIS - A LONG-TERM PROSPECTIVE OPEN-LABEL STUDY
F. Hanisch et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2009)
Treatment of Myasthenia Gravis exacerbation with intravenous immunoglobulin - A randomized double-blind clinical trial
P Gajdos et al.
ARCHIVES OF NEUROLOGY (2005)
Development of generalized disease at 2 years in patients with ocular myrasthenia gravis
MJ Kupersmith et al.
ARCHIVES OF NEUROLOGY (2003)
Share Paper
